Answers are grounded in this paper and cite their sources.
Di-n-butyl-, triphenyl and tri-n-butyltin derivatives of 3S,4S-3-[(R)-1-(tert-butyldimethyl-<?tw=103.5%>silyloxy)ethyl-4-[(R)-1-carboxyethyl]-2-azetidi<?tw>-none were synthesized and characterized. Their antitumour activity was screened against seven tumoural cell lines of human origin.
No takes yet. Share an insight, caveat, or question.
Gielen et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: